175 related articles for article (PubMed ID: 32752566)
21. Hepatitis A+B vaccine in elderly persons.
Wiedermann G
J Travel Med; 2004; 11(2):130-2. PubMed ID: 15109485
[No Abstract] [Full Text] [Related]
22. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
23. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010.
Costumbrado J; Stirland A; Cox G; El-Amin AN; Miranda A; Carter A; Malek M
Vaccine; 2012 Nov; 30(48):6878-82. PubMed ID: 22989688
[TBL] [Abstract][Full Text] [Related]
24. [Acute hepatitis A despite combined vaccination against hepatitis A and B--re the article from DMW 30/2002, page 1581-3].
Lander T
Dtsch Med Wochenschr; 2002 Nov; 127(46):2466-7; author reply 2467. PubMed ID: 12432491
[No Abstract] [Full Text] [Related]
25. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
26. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
28. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
Levie K; Beran J; Collard F; Nguyen C
Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
[TBL] [Abstract][Full Text] [Related]
29. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
[TBL] [Abstract][Full Text] [Related]
30. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
[TBL] [Abstract][Full Text] [Related]
31. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
32. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.
Murdoch DL; Goa K; Figgitt DP
Drugs; 2003; 63(23):2625-49. PubMed ID: 14636084
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
34. Combining hepatitis A and B vaccination in children and adolescents.
Van Damme P; Van der Wielen M
Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
[TBL] [Abstract][Full Text] [Related]
35. Long-term immunogenicity of two pediatric doses of combined hepatitis A and B or monovalent hepatitis B vaccine in 8 to 10-year-old children and the effect of a challenge dose given seven years later.
Gilca V; Dionne M; Boulianne N; Murphy D; De Serres G
Pediatr Infect Dis J; 2009 Oct; 28(10):916-8. PubMed ID: 19672212
[TBL] [Abstract][Full Text] [Related]
36. Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.
Hershey JH; Schowalter L; Bailey SB
Am J Med; 2005 Oct; 118 Suppl 10A():100S-108S. PubMed ID: 16271550
[TBL] [Abstract][Full Text] [Related]
37. Experience with hepatitis A and B vaccines.
Davis JP
Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
[TBL] [Abstract][Full Text] [Related]
38. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
[TBL] [Abstract][Full Text] [Related]
39. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis A and B vaccination and public health.
Hollinger FB; Bell B; Levy-Bruhl D; Shouval D; Wiersma S; Van Damme P
J Viral Hepat; 2007 Nov; 14 Suppl 1():1-5. PubMed ID: 17958635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
